Cyclooxygenase-2 inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Cyclooxygenase-2 inhibitor, covering 2016-10-28 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement [Phase 3]